Literature DB >> 8380075

Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.

A M Owsianka1, G Hart, M Murphy, J Gottlieb, R Boehme, M Challberg, H S Marsden.   

Abstract

To identify regions in the UL42 protein of herpes simplex virus type 1 which affect viral DNA polymerase activity, a series of 96 overlapping pentadecapeptides spanning the entire 488 amino acids of the UL42 protein were synthesized and tested for their ability to inhibit polymerase activity on a primed single-stranded M13 DNA template. Two assays were used: formation of full-length double-stranded M13 molecules and rate of incorporation of deoxyribonucleoside triphosphates. Peptides from five noncontiguous regions of the UL42 protein were found to inhibit herpes simplex virus type 1 polymerase activity in both the presence and absence of UL42 protein. The most active peptides from each region correspond to amino acids 23 to 38 (peptide 6), 64 to 78 (peptide 14), 89 to 102 (peptide 19), 229 to 243 (peptide 47), and 279 to 293 (peptide 57). By two different methods (DNA mobility shift and DNA precipitation), peptides 14, 19, 47, and 57 were found to bind DNA; they most probably inhibit enzyme activity by this mechanism. Peptide 6 did not bind DNA and must act by some mechanism other than competing for DNA. The inhibitory peptides were also tested for activity against mammalian polymerase alpha and the Klenow fragment of Escherichia coli polymerase. Although some limited specificity was demonstrated (up to 10-fold for peptide 6), all the peptides showed significant activity against both polymerase alpha and E. coli polymerase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380075      PMCID: PMC237359     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Herpes simplex virus proteins: DNA-binding proteins in infected cells and in the virus structure.

Authors:  G J Bayliss; H S Marsden; J Hay
Journal:  Virology       Date:  1975-11       Impact factor: 3.616

2.  Physical and genetic analysis of the herpes simplex virus DNA polymerase locus.

Authors:  P Chartrand; C S Crumpacker; P A Schaffer; N M Wilkie
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

3.  Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1.

Authors:  D S Parris; A Cross; L Haarr; A Orr; M C Frame; M Murphy; D J McGeoch; H S Marsden
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication.

Authors:  P Digard; W R Bebrin; K Weisshart; D M Coen
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

5.  Construction of a plasmid that overproduces the large proteolytic fragment (Klenow fragment) of DNA polymerase I of Escherichia coli.

Authors:  C M Joyce; N D Grindley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus.

Authors:  D M Coen; D P Aschman; P T Gelep; M J Retondo; S K Weller; P A Schaffer
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

7.  Binding of the herpes simplex virus type 1 UL9 gene product to an origin of viral DNA replication.

Authors:  H M Weir; J M Calder; N D Stow
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

8.  Mechanism of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. Specific binding of a photoaffinity analog, [4'- azido-Phe6] HSV H2-6(6-15), to subunit 1.

Authors:  H Paradis; P Gaudreau; P Brazeau; Y Langelier
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

9.  Herpes simplex virus DNA polymerase as the site of phosphonoacetate sensitivity: temperature-sensitive mutants.

Authors:  D J Purifoy; K L Powell
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

10.  Purification of the herpes simplex virus type 1 65-kilodalton DNA-binding protein: properties of the protein and evidence of its association with the virus-encoded DNA polymerase.

Authors:  M L Gallo; D H Jackwood; M Murphy; H S Marsden; D S Parris
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more
  6 in total

1.  Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit.

Authors:  Arianna Loregian; Brent A Appleton; James M Hogle; Donald M Coen
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Mutations that specifically impair the DNA binding activity of the herpes simplex virus protein UL42.

Authors:  C S Chow; D M Coen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  Two regions of the herpes simplex virus type 1 UL42 protein are required for its functional interaction with the viral DNA polymerase.

Authors:  S J Monahan; T F Barlam; C S Crumpacker; D S Parris
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

4.  Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface.

Authors:  P Digard; K P Williams; P Hensley; I S Brooks; C E Dahl; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  The catalytic subunit of the DNA polymerase of herpes simplex virus type 1 interacts specifically with the C terminus of the UL8 component of the viral helicase-primase complex.

Authors:  H S Marsden; G W McLean; E C Barnard; G J Francis; K MacEachran; M Murphy; G McVey; A Cross; A P Abbotts; N D Stow
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

6.  Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.

Authors:  Arianna Loregian; Roberto Rigatti; Mary Murphy; Elisabetta Schievano; Giorgio Palu; Howard S Marsden
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.